InvestorsHub Logo
Followers 62
Posts 4445
Boards Moderated 0
Alias Born 04/23/2013

Re: None

Wednesday, 10/30/2024 10:36:35 AM

Wednesday, October 30, 2024 10:36:35 AM

Post# of 437402
Ok, here's a look at the Consolidated Quarterly Income Statement for Q1 and Q2 along with my prognosis for Q3. You can fill in the blanks with your own estimates, but I see a -$9,000,000 hit on Product Revenue due mostly to the CVS loss, and only $5,000,000 positive in Licensing and Royalty (Down from $20,000,000 mostly from EdingPharm China Milestone payment). That brings us to $43,000,000 in Total Net Revenue vs. $67.5m in Q2. If we can further cut into Operating Expenses (under $39m) we may have a chance for a positive Quarter.

What do you think?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News